欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HU/V/0112/001
药品名称Tilmicosol 250 mg/ml concentrate for oral solution
活性成分
    • tilmicosin 250.0 mg/ml
剂型Oral solution
上市许可持有人Lavet Pharmaceuticals Ltd.
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Tilmicosol 250 mg/ml
    • Netherlands (NL)
    • France (FR)
    • Italy (IT)
    • Slovenia (SI)
    • Croatia (HR)
    • Denmark (DK)
      Tilmicosol
    • United Kingdom (Northern Ireland) (XI)
      Tilmicosol concentrate for oral solution
    • Spain (ES)
      TILMICOSOL 250 MG/ML CONCENTRADO PARA SOLUCIÓN ORAL PARA ADMINISTRACIÓ
    • Portugal (PT)
    • Greece (GR)
    • Poland (PL)
    • Lithuania (LT)
      Tilmicosol 250 mg/ml koncentratas geriamajam tirpalui
    • Cyprus (CY)
    • Czechia (CZ)
许可日期2010/11/24
最近更新日期2023/09/28
药物ATC编码
    • QJ01FA91 tilmicosin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase